1. Most Discussed
  2. Gainers & Losers
MGZ 1.6¢

Global Blood Collection Systems Market 2012-2016

  1. verce

    3,401 Posts.


    - Becton Dickinson & Co. (Market Cap: 27.5 billion)

    - Fresenius Kabi AG (Revenue: 20.3 billon)

    - Haemonetics Corp. (Market Cap: 2.2 billion)

    - Terumo Penpol Ltd. (Revenue: 4.2 billion)

    - Grifols SA (Market Cap: 4.5 billion)

    - Immucor Inc. (Acquired by TPG Capital for 1.97 billion)

    - Kawasumi Laboratories Inc. (Market Cap: 17.3 billion)

    - MacoPharma SA (couldn't find anything on this one)

    - Medigard Ltd. (Market Cap: 5.5 million)

    This little Australian company is mentioned alongside all these heavyweights. Medigard developed the vacuum retraction technology in-house. Medigard products contain fewer parts, are easier to manufacture and price competitive.

    http://www.medigard.com.au/files/me... Award for unique blood collection device.pdf

    ^Australian design award for unique blood collection device^

    This is a rare opportunity to get on board ahead of sales. Extensive product testing has found healthcare workers in the US and Australia unequivocally prefer Medigard's BCD to other products on the market.

Before making any financial decisions based on what you read, always consult an advisor or expert.

The HotCopper website is operated by Report Card Pty Ltd. Any information posted on the website has been prepared without taking into account your objectives, financial situation or needs and as such, you should before acting on the information or advice, consider the appropriateness of the information or advice in relation to your objectives, financial situation or needs. Please be aware that any information posted on this site should not be considered to be financial product advice.

From time to time comments aimed at manipulating other investors may appear on these forums. Posters may post overly optimistic or pessimistic comments on particular stocks, in an attempt to influence other investors. It is not possible for management to moderate all posts so some misleading and inaccurate posts may still appear on these forums. If you do have serious concerns with a post or posts you should report a Terms of Use Violation (TOU) on the link above. Unless specifically stated persons posting on this site are NOT investment advisors and do NOT hold the necessary licence, or have any formal training, to give investment advice.


Thank you for visiting HotCopper

We have detected that you are running ad blocking software.

HotCopper relies on revenue generated from advertisers. Kindly disable your ad blocking software to return to the HotCopper website.

I understand, I have disabled my ad blocker. Let me in!

Need help? Click here for support.